anthony@one2treat.com

A Study to Test the Effect of Survodutide on Cardiovascular Safety in People With Overweight or Obesity (2023)

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602a46a9c00bdc24e8b16fb_2560px-Boehringer_Ingelheim_Logo.svg.png

https://clinicaltrials.gov/study/NCT06077864

A Study of Retatrutide in Participants Who Have Obesity or Overweight (2023)

Click on the image below to view this study.

Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/66029c55c110e0bd19c1aaaa_512x512bb.jpg

On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/66029be45065148f50d2f160_PST-thumbnail.jpg

Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/66029b6409efa668bd4b2e3d_jacc.webp

Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/66029ae7f7a26a7b9c6a85aa_FZOipUcWYAEhH8S.png

Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/66029a5fab11a9ae96d3ce95_clinicaltrials.jpg

Generalized pairwise comparisons of prioritized outcomes in the two-sample problem

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602b16eb96b338e21f39ff7_stat%20med_crop.PNG

Generalized pairwise comparison methods to analyse (non)prioritized composite endpoints

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602b16eb96b338e21f39ff7_stat%20med_crop.PNG

Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: a simulation study

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602b16eb96b338e21f39ff7_stat%20med_crop.PNG

The asymptotic distribution of the net benefit estimator in the presence of censoring

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602b2e2a69be92705fcf4c0_Sage.png

Unbiasedness and efficiency of non-parametric and UMVUE estimators of the probabilistic index and related statistics

https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602b2e2a69be92705fcf4c0_Sage.png